Dr Sarah Redvers, a named safeguarding GP for NHS Sussex, has brought a constructive dismissal claim against the NHS Sussex Integrated Care Board and its former chief executive after she raised concerns about clinical practices at a gender treatment clinic. Redvers stated she faced investigation, bullying, and harassment after passing along complaints from other doctors regarding the assessment and treatment of young people questioning their gender identity.
The concerns centered on Dr Sam Hall, a GP at the WellBN practice in Brighton who had qualified in 2019. Multiple doctors contacted Redvers expressing worries about the quality of assessments, prescribing of puberty-blocking drugs and cross-sex hormones, and lack of specialist supervision. Redvers escalated these concerns through proper NHS channels, including to NHS England and the medical regulator, the GMC. Two separate NHS investigations into Hall’s work concluded there were no grounds for concern.
In June 2026, nearly six years after Redvers first raised her concerns, a separate NHS safety investigation found that 78 children, some as young as 13, had potentially been harmed through inappropriate prescriptions of puberty-blocking drugs and cross-sex hormones at the WellBN practice without proper checks. NHS England stated it was “totally unacceptable” that young people were put at risk because practitioners provided care they were not commissioned to deliver.
During the three-week employment tribunal hearing, Redvers testified that she felt medical and safeguarding issues were overshadowed by investigations into her conduct. She described undergoing what she characterized as a “brutal” four-hour interrogation, after which she took sick leave and received trauma treatment. NHS Surrey and Sussex acknowledged that some employment processes should have been handled differently and issued an apology to Redvers.
Redvers emphasized her concerns were about medical assessment and evidence-based treatment, particularly for vulnerable patients, rather than views on gender identity. She stated she regarded suggestions of transphobia as “appalling” and that such claims were “dangerous” because they obscured legitimate clinical and safeguarding issues.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI